Psychosocial Support for Cardiomyopathy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether joining a virtual support group can reduce anxiety in people with Takotsubo Syndrome, a temporary heart condition often triggered by stress. The focus is on determining if participation in this group decreases anxiety after one year. The trial seeks individuals diagnosed with Takotsubo Syndrome who are not currently receiving psychotherapy. As an unphased trial, it offers a unique opportunity to contribute to understanding the benefits of virtual support groups for anxiety reduction.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this support group is safe for participants with Takotsubo Syndrome?
Research has shown that support groups can help people with Takotsubo Syndrome, also known as stress-induced cardiomyopathy or broken heart syndrome. These groups offer a space to share experiences and learn from one another. Since this support doesn't involve medication or medical procedures, safety concerns are minimal.
Participants often feel less anxious and enjoy a sense of community, typically without experiencing negative effects. As support groups don't involve surgery or medical treatments, they are considered very safe.12345Why are researchers excited about this trial?
Researchers are excited about the Takotsubo Support Group because it's a fresh approach to managing Takotsubo Syndrome, also known as "broken heart syndrome." Unlike traditional treatments that focus on medications like beta-blockers or ACE inhibitors, this group offers psychosocial support, which can help address the emotional and psychological stressors often linked to this condition. By fostering a supportive community environment, participants may experience improved emotional resilience and potentially quicker recovery times. This approach highlights the importance of mental health in cardiomyopathy management, offering a holistic alternative to purely medical treatments.
What evidence suggests that the Takotsubo Support Group might be effective for reducing anxiety in cardiomyopathy patients?
Research shows that support groups can help people with Takotsubo Syndrome, also known as "broken heart syndrome." This condition affects the heart's ability to pump effectively. In this trial, participants will join a Takotsubo Support Group to share experiences and advice, which can benefit emotional health. While specific data on reducing anxiety is lacking, sharing feelings in a group often lowers stress. Medications like beta-blockers have not been proven to prevent Takotsubo, but emotional and social support play a crucial role in managing it. Joining a support group might help reduce anxiety and improve the overall quality of life for those affected.16789
Who Is on the Research Team?
Jim Cheung, MD
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for adults over 18 with a confirmed diagnosis of Takotsubo Syndrome, which is a type of heart condition. It's not open to those already in psychotherapy, non-English speakers, prisoners, pregnant women, or anyone unable to consent.Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are enrolled in a virtual Takotsubo support group to receive psychosocial support
Follow-up
Participants are monitored for changes in anxiety, quality of life, and depression
What Are the Treatments Tested in This Trial?
Interventions
- Takotsubo Support Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor